Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Semaglutide for Weight Loss: What the SURMOUNT-5 Results Mean for Northwest Louisiana Patients For the first time, a major clinical trial put tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) head to head in people with obesity who do not have diabetes, and the results landed in the New England Journal of Medicine in May 2025.[1] The short answer: tirzepatide produced significantly more weight loss
Users may experience mild to moderate discomfort at injection sites due to copper peptide irritation
Because this participant withdrew at V2, no subjective or objective data were available for analysis
Today, these drugs are helping millions of people gain better control over their blood sugar, lose weight, and reduce cardiovascular and other health risks
In addition, nausea may be reduced by eating smaller portions
US$ 29.37
US$ 24.24
US$ 20.97
US$ 21.26
US$ 28.89
US$ 21.49
US$ 24.00
US$ 29.64
US$ 20.42
US$ 29.54
US$ 27.02
